D. Di Paolo

发表

Combined Therapeutic Effects of Vinblastine and Rapamycin on Human Neuroblastoma Growth, Apoptosis, and Angiogenesis

D. Ribatti, B. Nico, M. Cilli, 2007, Clinical Cancer Research.

Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers.

A. Corti, F. Curnis, F. Pastorino, 2019, Small.

Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma.

V. Tumiatti, A. Milelli, A. Minarini, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Therapeutic targeting of TLR9 inhibits cell growth and induces apoptosis in neuroblastoma.

V. Pistoia, C. Gambini, F. Pastorino, 2010, Cancer research.

Neuroblastoma-targeted nanocarriers improve drug delivery and penetration, delay tumor growth and abrogate metastatic diffusion.

M. Cilli, S. Bruno, C. Tacchetti, 2015, Biomaterials.

The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients.

M. Cilli, W. Arap, F. Bussolino, 2015, Cancer research.

Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles.

D. Ribatti, M. Cilli, S. Bruno, 2018, Small.

Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK.

M. Cilli, S. Bruno, R. Chiarle, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

M. Cilli, W. Arap, R. Longhi, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.

D. Ribatti, B. Nico, M. Cilli, 2013, Journal of controlled release : official journal of the Controlled Release Society.

sTRAIL coupled to liposomes improves its pharmacokinetic profile and overcomes neuroblastoma tumour resistance in combination with Bortezomib.

M. Cilli, F. Pastorino, C. Brignole, 2014, Journal of controlled release : official journal of the Controlled Release Society.

PHOX2B-Mediated Regulation of ALK Expression: In Vitro Identification of a Functional Relationship between Two Genes Involved in Neuroblastoma

R. Chiarle, D. Fornasari, Ulrich Pfeffer, 2010, PloS one.

A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A

H. Tsukamoto, M. Ponzoni, J. Mann, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma.

D. Ribatti, M. Cilli, R. Chiarle, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Anti-IL-10R antibody improves the therapeutic efficacy of targeted liposomal oligonucleotides.

M. Cilli, V. Pistoia, G. Arrigoni, 2009, Journal of controlled release : official journal of the Controlled Release Society.

A novel liposomal Clodronate depletes tumor-associated macrophages in primary and metastatic melanoma: Anti-angiogenic and anti-tumor effects.

D. Ribatti, M. Pasparakis, V. Kondylis, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Drug Delivery Systems: Application of Liposomal Anti-Tumor Agents to Neuroectodermal Cancer Treatment

F. Pastorino, C. Brignole, D. Marimpietri, 2008, Tumori.

Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer

F. Pastorino, C. Brignole, M. Ponzoni, 2018, International journal of molecular sciences.

New therapeutic strategies in neuroblastoma: combined targeting of a novel tyrosine kinase inhibitor and liposomal siRNAs against ALK

M. Cilli, C. Liang, J. Gibbons, 2015, Oncotarget.

MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway

U. Pastorino, O. Fortunato, M. Boeri, 2022, Pharmaceuticals.

Combined Replenishment of miR-34a and let-7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models.

D. Ferrari, D. Brown, D. Ribatti, 2020, Small.

The Depolarization-Evoked, Ca2+-Dependent Release of Exosomes From Mouse Cortical Nerve Endings: New Insights Into Synaptic Transmission

A. Pittaluga, K. Cortese, M. Gagliani, 2021, Frontiers in Pharmacology.

Nanocarrier-Mediated Targeting of Tumor and Tumor Vascular Cells Improves Uptake and Penetration of Drugs into Neuroblastoma

F. Pastorino, C. Brignole, G. Pagnan, 2013, Front. Oncol..

Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models.

U. Pastorino, O. Fortunato, G. Sozzi, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Quiescent Hepatic Stellate Cells Functionally Contribute to the Hepatic Innate Immune Response via TLR3

Caroline L. Wilson, M. Karin, C. Brignole, 2014, PloS one.

A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in vivo

S. Hill, H. Marshall, C. Brignole, 2016, Journal of hepatology.

Neuroblastoma targeting by c-myb-selective antisense oligonucleotides entrapped in anti-GD2 immunoliposome: immune cell-mediated anti-tumor activities.

Chiara Brignole, Fabio Pastorino, Vito Pistoia, 2005, Cancer letters.

Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin

D. Ribatti, B. Nico, M. Cilli, 2008, Clinical Cancer Research.

Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.

Chiara Brignole, Fabio Pastorino, Vito Pistoia, 2006, Journal of the National Cancer Institute.

Liposome-mediated therapy of neuroblastoma.

C. Tacchetti, R. Longhi, A. Corti, 2009, Methods in enzymology.

Targeting liposomal chemotherapy via both tumor cell-specific and tumor vasculature-specific ligands potentiates therapeutic efficacy.

Chiara Brignole, Fabio Pastorino, Renato Longhi, 2006, Cancer research.

Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling

U. Pastorino, O. Fortunato, P. Suatoni, 2021, Molecular oncology.

Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.

D. Ribatti, B. Nico, M. Cilli, 2010, Journal of controlled release : official journal of the Controlled Release Society.

The use of the orthotopic model to validate antivascular therapies for cancer.

D. Ribatti, M. Cilli, F. Pastorino, 2011, The International journal of developmental biology.

Ligand-targeted liposomal therapies of neuroblastoma.

M. Cilli, T. Allen, F. Pastorino, 2007, Current medicinal chemistry.

The Combined Therapeutic Effects of Bortezomib and Fenretinide on Neuroblastoma Cells Involve Endoplasmic Reticulum Stress Response

D. Ribatti, B. Nico, M. Cilli, 2009, Clinical Cancer Research.

Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.

D. Ribatti, T. Allen, F. Pastorino, 2009, Current drug targets.

Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin

D. Ribatti, B. Nico, M. Cilli, 2008, Clinical Cancer Research.

Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings.

M. Cilli, W. Arap, R. Longhi, 2013, Journal of controlled release : official journal of the Controlled Release Society.

The Depolarization-Evoked, Ca2+-Dependent Release of Exosomes From Mouse Cortical Nerve Endings: New Insights Into Synaptic Transmission

A. Pittaluga, K. Cortese, M. Gagliani, 2020, Frontiers in Pharmacology.